Literature DB >> 8997206

Induction of human myeloblastic ML-1 cell G1 arrest by suppression of K+ channel activity.

B Xu1, B A Wilson, L Lu.   

Abstract

Our previous studies have shown that a voltage-gated K+ channel is highly expressed in proliferating human myeloblastic ML-1 cells and is suppressed in the early stages of 12-O-tetradecanoylphorbol-13-acetate-induced ML-1 cell differentiation. In the present study, we report that inhibition of the K+ channel activity by 4-aminopyridine (4-AP) suppressed ML-1 cell proliferation, as measured by DNA synthesis. Cell cycle mapping indicated that ML-1 cells were arrested in G1 phase after 24-h treatment with 4-AP. Blockade of ML-1 cells at the G1/S boundary of the cell cycle with aphidicolin revealed that ML-1 cells past the G1 checkpoint were capable of entering S phase and synthesizing DNA independently of the channel blockade. ML-1 cell differentiation, measured by CD14 marker protein expression, revealed that the effect of 4-AP was to cause growth arrest and that it did not cause differentiation. Dephosphorylation of retinoblastoma protein accompanied inhibition of ML-1 cell proliferation and suggested that suppression of K+ channel activity by 4-AP is associated with retinoblastoma protein-mediated G1 arrest in ML-1 cells. Moreover, we found that ML-1 cell volume increased 35 +/- 7% after 4-AP treatment, which could be an early event triggering inhibition of ML-1 cell proliferation. These findings suggest that a 4-AP-sensitive K+ channel may play an important role in the transduction of mitogenic signals in ML-1 cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997206     DOI: 10.1152/ajpcell.1996.271.6.C2037

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  14 in total

Review 1.  The influence of cell volume changes on tumour cell proliferation.

Authors:  Jean-Marc Dubois; Béatrice Rouzaire-Dubois
Journal:  Eur Biophys J       Date:  2003-11-04       Impact factor: 1.733

Review 2.  Stress-induced corneal epithelial apoptosis mediated by K+ channel activation.

Authors:  Luo Lu
Journal:  Prog Retin Eye Res       Date:  2006-09-07       Impact factor: 21.198

3.  TNF-alpha promotes cell survival through stimulation of K+ channel and NFkappaB activity in corneal epithelial cells.

Authors:  Ling Wang; Peter Reinach; Luo Lu
Journal:  Exp Cell Res       Date:  2005-10-10       Impact factor: 3.905

4.  Okadaic acid suppresses TPA-induced differentiation by stimulating G1/S transition in human myeloblastic leukaemia ML-1 cells.

Authors:  P S Reinach; T Li; L Lu
Journal:  Cell Prolif       Date:  2000-08       Impact factor: 6.831

5.  A cytoplasmic cell cycle controls the activity of a K+ channel in pre-implantation mouse embryos.

Authors:  M L Day; M H Johnson; D I Cook
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

6.  Roles of volume-activated Cl- currents and regulatory volume decrease in the cell cycle and proliferation in nasopharyngeal carcinoma cells.

Authors:  L X Chen; L Y Zhu; T J C Jacob; L W Wang
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

7.  K+ channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation.

Authors:  B Rouzaire-Dubois; J M Dubois
Journal:  J Physiol       Date:  1998-07-01       Impact factor: 5.182

8.  Modulation of rabbit corneal epithelial cell proliferation by growth factor-regulated K(+) channel activity.

Authors:  C Roderick; P S Reinach; L Wang; L Lu
Journal:  J Membr Biol       Date:  2003-11-01       Impact factor: 1.843

9.  Functional role of CCCTC binding factor in insulin-stimulated cell proliferation.

Authors:  J Gao; T Li; L Lu
Journal:  Cell Prolif       Date:  2007-12       Impact factor: 6.831

Review 10.  Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications.

Authors:  E D Burg; C V Remillard; J X-J Yuan
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.